CPC C07D 413/12 (2013.01) [C07D 267/10 (2013.01); C07D 413/14 (2013.01); C07D 417/12 (2013.01); C07F 9/6527 (2013.01)] | 12 Claims |
1. A compound, or the stereoisomer, deuterated product, solvate or pharmaceutically acceptable salt thereof, wherein the compound has a structure of formula (IV):
wherein
Rc is H, halogen, C1-2 alkyl or C1-2 alkoxy;
R1, R2, and R3 are each independently selected from H, deuterium, F, Cl, Br, methyl, ethyl, methoxy or ethoxy, and the methyl, ethyl, methoxy or ethoxy is optionally substituted with 1-3 groups selected from F, Cl, Br, cyano, hydroxyl, and NH2;
Z is CH or N;
ring G is
or a benzene ring, each of which is optionally substituted with 1-2 RG groups; and
each RG is independently selected from F, Cl, Br, I, methyl, ethyl, propyl, SF5 and CN, wherein the methyl, ethyl or propyl is optionally further substituted with 1-3 groups selected from deuterium, F, Cl, Br, and I.
|